Clinical Physiology of Circulation

Chief Editor

Leo A. Bockeria, MD, PhD, DSc, Professor, Academician of Russian Academy of Sciences, President of Bakoulev National Medical Research Center for Cardiovascular Surgery


Development of acute non-cardiogenic pulmonary edema in patients with a history of COVID-19 who underwent cardiac surgery

Authors: Rybka M.M., Goncharov A.A., Yudin G.V., Nurkaev M.T., Chegrina L.V., Kudaev K.A.

Company:
Bakoulev National Medical Research Center for Cardiovascular Surgery, Moscow, Russian Federation

E-mail: Сведения доступны для зарегистрированных пользователей.

DOI: https://doi.org/10.24022/1814-6910-2023-20-4-403-410

UDC: 616.24-005.98:578.834.11

Link: Clinical Physiology of Blood Circulaiton. 2023; 4 (20): 403-410

Quote as: Rybka M.M., Goncharov A.A., Yudin G.V., Nurkaev M.T., Chegrina L.V., Kudaev K.A. Development of acute noncardiogenic pulmonary edema in patients with a history of COVID-19 who underwent cardiac surgery. Clinical Physiology of Circulation. 2023; 20 (4): 403–10 (in Russ.). DOI: 10.24022/1814-6910-2023-20-4-403-410

Received / Accepted:  26.10.2023 / 22.12.2023

Download
Full text:  

Abstract

The clinical observation of acute noncardiogenic pulmonary edema in two patients who underwent surgery under bypass is described. Postoperative pulmonary edema is a common occurrence in cardiac surgery. Most often, it is caused by left ventricular (LV) dysfunction and has a number of characteristic signs. First of all, an increase in the pulmonary capillary wedge pressure (PCWP) with a decrease in LV contractility. The changes in the radiographs of the patients presented reflect a large amount of fluid in the pulmonary interstitium. In the described cases, LV pumping function remained normal. The PCWP did not exceed 18 mmHg. Accordingly, there was a second pathophysiological variant of pulmonary edema – noncardiogenic (increased permeability). It was not possible to detect any factors that could be associated with increased vascular permeability, with the exception of COVID-19 with a severe history in patients.

References

  1. Huppert L.A., Matthay M.A., Ware L.B. Pathogenesis of acute respiratory distress syndrome. Semin. Respir. Crit. Care Med. 2019; 40 (1): 31–9. DOI: 10.1055/s-0039-1683996
  2. Dobbe L., Rahman R., Elmassry M., Paz P., Nugent K. Cardiogenic pulmonary edema. Am. J. Med. Sci. 2019; 358 (6): 389–97. DOI: 10.1016/j.amjms.2019.09.011
  3. Zanza C., Saglietti F., Tesauro M., Longhitano Y., Savioli G., Balzanelli M.G. et al. Cardiogenic pulmonary edema in emergency medicine. Adv. Respir. Med. 2023; 91 (5): 445–63. DOI: 10.3390/arm91050034 Wautier J.L., Wautier M.P. Vascular permeability in diseases. Int. J. Mol. Sci. 2022; 23 (7): 3645. DOI: 10.3390/ijms23073645
  4. Lai Y., Huang Y. Mechanisms of mechanical force induced pulmonary vascular endothelial hyperpermeability. Front. Physiol. 2021; 12: 714064. DOI: 10.3389/fphys.2021.714064
  5. Saguil A., Fargo M.V. Acute respiratory distress syndrome: diagnosis and management. Am. Fam. Physician. 2020; 101 (12): 730–8. PMID: 32538594
  6. Chen S.W., Chang C.H., Chu P.H., Chen T.H., Wu V.C., Huang Y.K. et al. Risk factor analysis of postoperative acute respiratory distress syndrome in valvular heart surgery. J. Crit. Care. 2016; 31 (1): 139–43. DOI: 10.1016/j.jcrc.2015.11.002
  7. Rong L.Q., Di Franco A., Gaudino M. Acute respiratory distress syndrome after cardiac surgery. J. Thorac. Dis. 2016; 8 (10): E1177–E1186. DOI: 10.21037/jtd.2016.10.74
  8. Murray J.F. Pulmonary edema: pathophysiology and diagnosis. Int. J. Tuberc. Lung. Dis. 2011; 15 (2): 155– 60. PMID: 21219673
  9. Ghosn J., Piroth L., Epaulard O., Le Turnier P., Mentré F., Bachelet D. et al. French COVID cohort study and investigators groups. Persistent COVID-19 symptoms are highly prevalent 6 months after hospitalization: results from a large prospective cohort. Clin. Microbiol. Infect. 2021; 27 (7): 1041.e1–1041.e4. DOI: 10.1016/j.cmi.2021.03.012
  10. Huang L., Yao Q., Gu X., Wang Q., Ren L., Wang Y. et al. 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study. Lancet. 2021; 398 (10302): 747–58. DOI: 10.1016/S0140-6736(21)01755-4. Erratum in: Lancet. 2022; 399 (10337): 1778. PMID: 34454673
  11. Wang X., Gao H., Zhang Z., Deng C., Yan Y., Shi T. Effect of the COVID-19 pandemic on complications and mortality of patients with cardiac surgery. J. Cardiothorac. Surg. 2021; 16 (1): 361. DOI: 10.1186/s13019-021-01744-z
  12. Boeken U., Holst T., Hettlich V., Dörge H., Böning A., Lichtenberg A. Auswirkungen der COVID-19- pandemie auf die herzchirurgie [Impact of the COVID-19 pandemic on cardiac surgery]. Z. Herz. Thorax. Gefasschir. 2022; 36 (5): 284–91 (in Ger.). DOI: 10.1007/s00398-022-00539-1
  13. Hoffmann M., Kleine-Weber H., Schroeder S., Krüger N., Herrler T., Erichsen S. et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020; 181 (2): 271– 280.e8. DOI: 10.1016/j.cell.2020.02.052
  14. Michalick L., Weidenfeld S., Grimmer B., Fatykhova D., Solymosi P.D., Behrens F. et al. Plasma mediators in patients with severe COVID-19 cause lung endothelial barrier failure. Eur. Respir. J. 2021; 57 (3): 2002384. DOI: 10.1183/13993003.02384-2020
  15. Tay M.Z., Poh C.M., Rénia L., MacAry P.A., Ng L.F.P. The trinity of COVID-19: immunity, inflammation and intervention. Nat. Rev. Immunol. 2020; 20 (6): 363–74. DOI: 10.1038/s41577-020-0311-8
  16. McGonagle D., O'Donnell J.S., Sharif K., Emery P., Bridgewood C. Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia. Lancet Rheumatol. 2020; 2 (7): e437–e445. DOI: 10.1016/S2665- 9913(20)30121-1
  17. Чучалин А.Г. Отек легких. Физиология малого круга кровообращения и патофизиология отека легких. Терапевтический архив. 2006; 78 (3): 5–13. PMID: 17019950
  18. Власенко А.В., Голубев А.М., Алексеев В.Г., Булатов Н.Н., Евдокимов Е.А. Механизмы патогенеза, диагностика и лечение острого респираторного дистресс-синдрома. Часть I. Медицинский алфавит. 2017; 1 (5): 5–13.
  19. Ismail N.A., Jaapar A.N., Yunus A.M., Sanusi A.R., Taib M.E., Yakub M.A. Outcome of adult cardiac surgery following COVID-19 infection in unvaccinated population in a national tertiary centre. PLoS One. 2022; 17 (4): e0266056. DOI: 10.1371/journal.pone.0266056
****
  1. Huppert L.A., Matthay M.A., Ware L.B. Pathogenesis of acute respiratory distress syndrome. Semin. Respir. Crit. Care Med. 2019; 40 (1): 31–9. DOI: 10.1055/s-0039-1683996
  2. Dobbe L., Rahman R., Elmassry M., Paz P., Nugent K. Cardiogenic pulmonary edema. Am. J. Med. Sci. 2019; 358 (6): 389–97. DOI: 10.1016/j.amjms.2019.09.011
  3. Zanza C., Saglietti F., Tesauro M., Longhitano Y., Savioli G., Balzanelli M.G. et al. Cardiogenic pulmonary edema in emergency medicine. Adv. Respir. Med. 2023; 91 (5): 445–63. DOI: 10.3390/arm91050034 Wautier J.L., Wautier M.P. Vascular permeability in diseases. Int. J. Mol. Sci. 2022; 23 (7): 3645. DOI: 10.3390/ijms23073645
  4. Lai Y., Huang Y. Mechanisms of mechanical force induced pulmonary vascular endothelial hyperpermeability. Front. Physiol. 2021; 12: 714064. DOI: 10.3389/fphys.2021.714064
  5. Saguil A., Fargo M.V. Acute respiratory distress syndrome: diagnosis and management. Am. Fam. Physician. 2020; 101 (12): 730–8. PMID: 32538594
  6. Chen S.W., Chang C.H., Chu P.H., Chen T.H., Wu V.C., Huang Y.K. et al. Risk factor analysis of postoperative acute respiratory distress syndrome in valvular heart surgery. J. Crit. Care. 2016; 31 (1): 139–43. DOI: 10.1016/j.jcrc.2015.11.002
  7. Rong L.Q., Di Franco A., Gaudino M. Acute respiratory distress syndrome after cardiac surgery. J. Thorac. Dis. 2016; 8 (10): E1177–E1186. DOI: 10.21037/jtd.2016.10.74
  8. Murray J.F. Pulmonary edema: pathophysiology and diagnosis. Int. J. Tuberc. Lung. Dis. 2011; 15 (2): 155– 60. PMID: 21219673
  9. Ghosn J., Piroth L., Epaulard O., Le Turnier P., Mentré F., Bachelet D. et al. French COVID cohort study and investigators groups. Persistent COVID-19 symptoms are highly prevalent 6 months after hospitalization: results from a large prospective cohort. Clin. Microbiol. Infect. 2021; 27 (7): 1041.e1–1041.e4. DOI: 10.1016/j.cmi.2021.03.012
  10. Huang L., Yao Q., Gu X., Wang Q., Ren L., Wang Y. et al. 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study. Lancet. 2021; 398 (10302): 747–58. DOI: 10.1016/S0140-6736(21)01755-4. Erratum in: Lancet. 2022; 399 (10337): 1778. PMID: 34454673
  11. Wang X., Gao H., Zhang Z., Deng C., Yan Y., Shi T. Effect of the COVID-19 pandemic on complications and mortality of patients with cardiac surgery. J. Cardiothorac. Surg. 2021; 16 (1): 361. DOI: 10.1186/s13019-021-01744-z
  12. Boeken U., Holst T., Hettlich V., Dörge H., Böning A., Lichtenberg A. Auswirkungen der COVID-19- pandemie auf die herzchirurgie [Impact of the COVID-19 pandemic on cardiac surgery]. Z. Herz. Thorax. Gefasschir. 2022; 36 (5): 284–91 (in Ger.). DOI: 10.1007/s00398-022-00539-1
  13. Hoffmann M., Kleine-Weber H., Schroeder S., Krüger N., Herrler T., Erichsen S. et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020; 181 (2): 271– 280.e8. DOI: 10.1016/j.cell.2020.02.052
  14. Michalick L., Weidenfeld S., Grimmer B., Fatykhova D., Solymosi P.D., Behrens F. et al. Plasma mediators in patients with severe COVID-19 cause lung endothelial barrier failure. Eur. Respir. J. 2021; 57 (3): 2002384. DOI: 10.1183/13993003.02384-2020
  15. Tay M.Z., Poh C.M., Rénia L., MacAry P.A., Ng L.F.P. The trinity of COVID-19: immunity, inflammation and intervention. Nat. Rev. Immunol. 2020; 20 (6): 363–74. DOI: 10.1038/s41577-020-0311-8
  16. McGonagle D., O'Donnell J.S., Sharif K., Emery P., Bridgewood C. Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia. Lancet Rheumatol. 2020; 2 (7): e437–e445. DOI: 10.1016/S2665- 9913(20)30121-1
  17. Chuchalin A.G. Pulmonary edema. Physiology of the small circle of blood circulation and pathophysiology of pulmonary edema. Terapevtichesii Arkhiv. 2006; 78 (3): 5–13 (in Russ.). PMID: 17019950
  18. Vlasenko A.V., Golubev A.M., Alekseev V.G., Bulatov N.N., Evdokimov E.A. Mechanisms of pathogenesis, diagnosis and treatment of acute respiratory distress syndrome. Part I. Medical Alphabet. 2017; 1 (5): 5–13 (in Russ.).
  19. Ismail N.A., Jaapar A.N., Yunus A.M., Sanusi A.R., Taib M.E., Yakub M.A. Outcome of adult cardiac surgery following COVID-19 infection in unvaccinated population in a national tertiary centre. PLoS One. 2022; 17 (4): e0266056. DOI: 10.1371/journal.pone.0266056

About Authors

  • Mikhail M. Rybka, Dr. Med. Sci., Deputy Director for Anesthesiology and Reanimatology, Head of Department of Anesthesiology, Resuscitation and Intensive Care with Early Rehabilitation Group; ORCID
  • Andrey A. Goncharov, Cand. Med. Sci., Anesthesiologist-Intensivist; ORCID
  • Gennadiy V. Yudin, Dr. Med. Sci., Head of Department of Reanimation and Intensive Care for Adults; ORCID
  • Marufzhon T. Nurkaev, Postgraduate, Institute of Experts Training and Professional Development at Bakoulev Center; ORCID
  • Lyubov V. Chegrina, Cand. Med. Sci., Anesthesiologist-Intensivist; ORCID
  • Kantemir A. Kudaev, Anesthesiologist-Intensivist; ORCID

 If you found mistakes, select text and press Alt+A